These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3548315)

  • 21. Interferon alternating with chemotherapy for patients with metastatic renal cell carcinoma.
    Dexeus FH; Logothetis CJ; Sella A; Finn L
    Am J Clin Oncol; 1989 Aug; 12(4):350-4. PubMed ID: 2667326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase-III clinical trial of adjuvant FAM2 (5-FU, adriamycin and mitomycin C) vs control in resectable gastric cancer: a study of the EORTC Gastrointestinal Tract Cancer Cooperative Group.
    Lise M; Nitti D; Buyse M; Cartei G; Fornasiero A; Guimaraes dos Santos J; Duez N
    Recent Results Cancer Res; 1988; 110():36-43. PubMed ID: 3043595
    [No Abstract]   [Full Text] [Related]  

  • 23. Pegylated liposomal doxorubicin, 5-fluorouracil and cisplatin versus mitomycin-C, 5-fluorouracil and cisplatin for advanced gastric cancer: a randomized phase II trial.
    Cascinu S; Galizia E; Labianca R; Ferraù F; Pucci F; Silva RR; Luppi G; Beretta GD; Berardi R; Scartozzi M
    Cancer Chemother Pharmacol; 2011 Jul; 68(1):37-43. PubMed ID: 20821330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Etoposide/cisplatin-based chemotherapy for patients with metastatic poorly differentiated carcinoma of unknown primary site.
    Greco FA; Johnson DH; Hainsworth JD
    Semin Oncol; 1992 Dec; 19(6 Suppl 13):14-8. PubMed ID: 1492223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin.
    Cullinan SA; Moertel CG; Fleming TR; Rubin JR; Krook JE; Everson LK; Windschitl HE; Twito DI; Marschke RF; Foley JF
    JAMA; 1985 Apr; 253(14):2061-7. PubMed ID: 2579257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of hormone-resistant metastatic carcinoma of the prostate with 5-FU, doxorubicin, and mitomycin (FAM'): a preliminary report.
    Kasimis BS; Moran EM; Miller JB; Forbes KA; Kaneshiro CA; Poblet MT; Williams JL
    Cancer Treat Rep; 1983 Oct; 67(10):937-9. PubMed ID: 6688755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adriamycin (doxorubicin), vinblastine, and mitomycin C combination chemotherapy in refractory breast carcinoma.
    Luikart SD; Witman GB; Portlock CS
    Cancer; 1984 Oct; 54(7):1252-5. PubMed ID: 6467151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma.
    Shimaoka K; Schoenfeld DA; DeWys WD; Creech RH; DeConti R
    Cancer; 1985 Nov; 56(9):2155-60. PubMed ID: 3902203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Doxorubicin and cyclophosphamide, alternated with bleomycin and mitomycin C as a second-line regimen in advanced ovarian carcinoma resistant to cisplatin-based chemotherapy.
    Benedetti Panici P; Scambia G; Greggi S; Salerno G; Cento R; Mancuso S
    Oncology; 1990; 47(4):296-8. PubMed ID: 1694980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adriamycin and mitomycin C as initial chemotherapy for advanced breast cancer.
    Amiel SA; Stewart JF; Earl HM; Knight RK; Rubens RD
    Eur J Cancer Clin Oncol; 1984 May; 20(5):631-4. PubMed ID: 6428893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differing response rates and survival between squamous and non-squamous non-small cell lung cancer. Comparison of CAP versus MAP.
    Eagan RT; Frytak S; Creagan ET; Richardson RL; Coles DT; Jett JR
    Am J Clin Oncol; 1986 Jun; 9(3):249-54. PubMed ID: 3755281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trial of the combination of mitomycin, vindesine, and cisplatin in patients with advanced non-small cell lung cancer.
    Kris MG; Gralla RJ; Wertheim MS; Kelsen DP; O'Connell JP; Burke MT; Fiore JJ; Cibas IR; Heelan RT
    Cancer Treat Rep; 1986 Sep; 70(9):1091-6. PubMed ID: 3527408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitomycin C, epirubicin and cisplatin versus mitomycin C alone as therapy for carcinoma of unknown primary origin.
    Falkson CI; Cohen GL
    Oncology; 1998; 55(2):116-21. PubMed ID: 9499185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluorouracil, doxorubicin, cisplatin and altretamine in the treatment of metastatic carcinoma of unknown primary.
    Bécouarn Y; Brunet R; Barbé-Gaston C
    Eur J Cancer Clin Oncol; 1989 May; 25(5):861-5. PubMed ID: 2500343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized trial fo three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): a study of the Umbrian Lung Cancer Group.
    Crino L; Tonato M; Darwish S; Meacci ML; Corgna E; Di Costanzo F; Buzzi F; Fornari G; Santi E; Ballatori E
    Cancer Chemother Pharmacol; 1990; 26(1):52-6. PubMed ID: 2157554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotherapy of hormonally unresponsive prostatic carcinoma.
    deKernion JB; Lindner A
    Urol Clin North Am; 1984 May; 11(2):319-26. PubMed ID: 6233779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic arterial chemotherapy and occlusion for palliation of primary hepatocellular and unknown primary neoplasms in the liver.
    Patt YZ; Chuang VP; Wallace S; Benjamin RS; Fuqua R; Mavligit GM
    Cancer; 1983 Apr; 51(8):1359-63. PubMed ID: 6186357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cisplatin-cyclophosphamide-mitomycin combination chemotherapy with supportive care versus supportive care alone for treatment of metastatic non-small-cell lung cancer.
    Cartei G; Cartei F; Cantone A; Causarano D; Genco G; Tobaldin A; Interlandi G; Giraldi T
    J Natl Cancer Inst; 1993 May; 85(10):794-800. PubMed ID: 8387607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The benefit of cisplatin-based polychemotherapy for adenocarcinoma of the lung. The Kyushu Lung Cancer Chemotherapy Study Group.
    Hara N; Ohta M; Ichikawa Y; Kanda T; Shima K; Tamura K; Hokama M
    Cancer Chemother Pharmacol; 1990; 26(1):47-51. PubMed ID: 2108816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alternating chemotherapy in advanced gastric cancer. A phase II study.
    Feliu J; Girón CG; González-Baron M; Berrocal A; Barón-Saura JM
    Cancer Chemother Pharmacol; 1991; 28(4):313-4. PubMed ID: 1908751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.